Related Experiment Videos
Pediatric heart and lung transplantation
Subash C Reddy1, Steven A Webber
1Pediatric Heart and Heart-Lung Transplantation Program, Division of Cardiology, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA.
Indian Journal of Pediatrics
|November 19, 2003
Summary
Pediatric heart transplant survival has improved due to medical advances. However, non-specific immunosuppression causes side effects, necessitating research into tolerance for better long-term outcomes.
Area of Science:
- Pediatric Cardiology
- Transplantation Immunology
- Immunosuppression Therapy
Background:
- Significant improvements in medium-term survival and quality of life for pediatric heart transplant recipients over the past two decades.
- Advances include better donor/recipient selection, surgical expertise for complex congenital heart disease, improved rejection surveillance, and broader immunosuppressive medication options.
Purpose of the Study:
- To review advances in pediatric heart transplantation and address the limitations of current immunosuppressive strategies.
- To highlight the ongoing pursuit of inducing immune tolerance in transplant recipients to eliminate the need for long-term immunosuppression.
Main Methods:
- Review of recent advancements in pediatric heart transplantation.
- Analysis of the adverse effects associated with non-specific immunosuppression.
- Discussion of the immunologic mechanisms underlying rejection and graft acceptance.
Main Results:
- Despite progress, pediatric heart transplant recipients experience significant toxicities from non-specific immunosuppression, including infections, malignancies, and renal dysfunction.
- Current immunosuppressive regimens have shown limited impact on allograft coronary vasculopathy (chronic rejection).
Conclusions:
- Further understanding of immunologic mechanisms is crucial for developing targeted immunosuppressive therapies.
- The ultimate goal is to achieve immune tolerance, enabling indefinite allograft acceptance without long-term immunosuppression while maintaining overall immunocompetence.